Status:
UNKNOWN
Ventricular Pacing Site Selection (V-PASS)
Lead Sponsor:
Medtronic BRC
Collaborating Sponsors:
Vitatron GmbH
Conditions:
Atrioventricular Block
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether there is a relationship between ventricular lead position and the incidence of heart failure and atrial fibrillation in patients with indication for p...
Detailed Description
AV-Block of higher degree is the primary indication for pacing therapy for about 20% of pacemaker patients. Pacing systems with only ventricular stimulation (VVI and VDD) have a fraction of about 40% ...
Eligibility Criteria
Inclusion
- Patients with an expected ventricular stimulation rate of \>60% in planned pacing therapy. This will be the following pacing indications
- Symptomatic first-degree AV block, PQ time \>250ms
- Second-degree Av block with permanent 2:1 conduction
- Permanent third-degree AV block
- Paroxysmal first-degree to third-degree Av block, with an anticipated rate of ventricular stimulation \>60%
- Symptomatic bradyarrhythmia absoluta with permanent atrial fibrillation, with an anticipated rate of ventricular stimulation \>60%
Exclusion
- heart failure acc. NYHA III or IV
- Intra-atrial conduction delay (P-wave \> 150ms)
- Myocardial infarction less then 6 months before pacemaker implant
- hypertrophic obstructive cardiomyopathy
- Cardiogenic shock
- pregnancy
- Lactation period
- Patients under 18 years of age
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00292383
End Date
December 1 2008
Last Update
August 2 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Herzzentrum Bad Krozingen, Elektrophysiologie
Bad Krozingen, Germany, D-79189
2
Universitätsklinikum Heidelberg, Innere Medizin III
Heidelberg, Germany, D-69120
3
Oberschwaben Klinik GmbH, Krankenhaus Wangen, Innere Med.
Wangen, Germany, D-88239